Dahlbäck B, Villoutreix BO. Molecular recognition in the protein C anticoagulant pathway. J Thrombosis Haemostasis: JTH. 2003;1:1525–34.

Esmon CT. The protein C pathway. Chest. 2003;124:26s–32s.

Article  CAS  PubMed  Google Scholar 

Castellino FJ, Ploplis VA. The protein C pathway and pathologic processes. J Thrombosis Haemost: JTH. 2009;7:140–5.

Article  CAS  PubMed Central  Google Scholar 

Bouwens EA, Stavenuiter F, Mosnier LO. Mechanisms of anticoagulant and cytoprotective actions of the protein C pathway. J Thrombosis Haemost: JTH. 2013;11:242–53.

Article  PubMed  PubMed Central  Google Scholar 

Leon G, Rehill AM, Preston RJS. The protein C pathways. Curr Opin Hematol. 2022;29:251–8.

Article  CAS  PubMed  Google Scholar 

Khan F, Tritschler T, Kahn SR, Rodger MA. Venous thromboembolism. Lancet (Lond, Engl). 2021;398:64–77.

Article  CAS  Google Scholar 

Schulman S, Ageno W, Konstantinides SV. Venous thromboembolism: Past, present and future. Thrombosis Haemost. 2017;117:1219–29.

Article  Google Scholar 

The Human Gene Mutation Database 2025 [Available from: https://www.hgmd.cf.ac.uk.

Tang L, Hu Y. Ethnic diversity in the genetics of venous thromboembolism. Thrombosis Haemost. 2015;114:901–9.

Article  Google Scholar 

Simioni P, Tormene D, Spiezia L, Tognin G, Rossetto V, Radu C, et al. Inherited thrombophilia and venous thromboembolism. Semin Thrombosis Hemost. 2006;32:700–8.

Article  CAS  Google Scholar 

Minford A, Brandão LR, Othman M, Male C, Abdul-Kadir R, Monagle P, et al. Diagnosis and management of severe congenital protein C deficiency (SCPCD): Communication from the SSC of the ISTH. J Thrombosis Haemost: JTH. 2022;20:1735–43.

Article  CAS  PubMed  Google Scholar 

Goldenberg NA, Manco-Johnson MJ. Protein C deficiency. Haemoph: J World Federation Hemophilia. 2008;14:1214–21.

Article  CAS  Google Scholar 

Chiasakul T, De Jesus E, Tong J, Chen Y, Crowther M, Garcia D, et al. Inherited thrombophilia and the risk of arterial ischemic stroke: a systematic review and meta-analysis. J Am Heart Assoc. 2019;8:e012877.

Article  PubMed  PubMed Central  Google Scholar 

Mahmoodi BK, Brouwer JL, Veeger NJ, van der Meer J. Hereditary deficiency of protein C or protein S confers increased risk of arterial thromboembolic events at a young age: results from a large family cohort study. Circulation. 2008;118:1659–67.

Article  CAS  PubMed  Google Scholar 

Tait RC, Walker ID, Reitsma PH, Islam SI, McCall F, Poort SR, et al. Prevalence of protein C deficiency in the healthy population. Thrombosis Haemost. 1995;73:87–93.

Article  CAS  Google Scholar 

Zhu XJ, Liu ZY, Wang PW, Wang J, Wen SD, Zhang JX, et al. Congenital thrombophilia in East-Asian venous thromboembolism population: a systematic review and meta-analysis. Res Pr Thrombosis Haemost. 2023;7:102157.

Article  CAS  Google Scholar 

Manco-Johnson MJ, Bomgaars L, Palascak J, Shapiro A, Geil J, Fritsch S, et al. Efficacy and safety of protein C concentrate to treat purpura fulminans and thromboembolic events in severe congenital protein C deficiency. Thrombosis Haemost. 2016;116:58–68.

Article  Google Scholar 

Prosser A, Amos L, Sharma M. Novel prenatal diagnosis of protein C deficiency and primary prophylaxis with protein C concentrate. Thrombosis Res. 2021;208:145–7.

Article  CAS  Google Scholar 

Kasahara M, Hong JC, Dhawan A. Evaluation of living donors for hereditary liver disease (siblings, heterozygotes). J Hepatol. 2023;78:1147–56.

Article  CAS  PubMed  Google Scholar 

Brouwer JL, Lijfering WM, Ten Kate MK, Kluin-Nelemans HC, Veeger NJ, van der Meer J. High long-term absolute risk of recurrent venous thromboembolism in patients with hereditary deficiencies of protein S, protein C or antithrombin. Thrombosis Haemost. 2009;101:93–9.

Article  CAS  Google Scholar 

Vossen CY, Walker ID, Svensson P, Souto JC, Scharrer I, Preston FE, et al. Recurrence rate after a first venous thrombosis in patients with familial thrombophilia. Arteriosclerosis, thrombosis, Vasc Biol. 2005;25:1992–7.

Article  CAS  Google Scholar 

Roth TL, Marson A. Genetic disease and therapy. Annu Rev Pathol. 2021;16:145–66.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Raguram A, Banskota S, Liu DR. Therapeutic in vivo delivery of gene editing agents. Cell. 2022;185:2806–27.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kaufmann KB, Büning H, Galy A, Schambach A, Grez M. Gene therapy on the move. EMBO Mol Med. 2013;5:1642–61.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bulcha JT, Wang Y, Ma H, Tai PWL, Gao G. Viral vector platforms within the gene therapy landscape. Signal Transduct Target Ther. 2021;6:53.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pupo A, Fernández A, Low SH, François A, Suárez-Amarán L, Samulski RJ. AAV vectors: The Rubik’s cube of human gene therapy. Mol Ther: J Am Soc Gene Ther. 2022;30:3515–41.

Article  CAS  Google Scholar 

Issa SS, Shaimardanova AA, Solovyeva VV, Rizvanov AA. Various AAV Serotypes and Their Applications in Gene Therapy: An Overview. Cells. 2023;12:5.

Article  Google Scholar 

Mendell JR, Al-Zaidy SA, Rodino-Klapac LR, Goodspeed K, Gray SJ, Kay CN, et al. Current clinical applications of in vivo gene therapy with AAVs. Mol Ther: J Am Soc Gene Ther. 2021;29:464–88.

Article  CAS  Google Scholar 

Maguire AM, Russell S, Wellman JA, Chung DC, Yu ZF, Tillman A, et al. Efficacy, safety, and durability of voretigene neparvovec-rzyl in RPE65 mutation-associated inherited retinal dystrophy: results of phase 1 and 3 trials. Ophthalmology. 2019;126:1273–85.

Article  PubMed  Google Scholar 

Strauss KA, Farrar MA, Muntoni F, Saito K, Mendell JR, Servais L, et al. Onasemnogene abeparvovec for presymptomatic infants with three copies of SMN2 at risk for spinal muscular atrophy: the Phase III SPR1NT trial. Nat Med. 2022;28:1390–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Blair HA. Valoctocogene roxaparvovec: first approval. Drugs. 2022;82:1505–10.

Article  PubMed  Google Scholar 

Heo YA. Etranacogene dezaparvovec: first approval. Drugs. 2023;83:347–52.

Article  CAS  PubMed  Google Scholar 

Geddings J, Aleman MM, Wolberg A, von Brühl ML, Massberg S, Mackman N. Strengths and weaknesses of a new mouse model of thrombosis induced by inferior vena cava stenosis: communication from the SSC of the ISTH. J Thrombosis Haemost: JTH. 2014;12:571–3.

Article  CAS  PubMed  Google Scholar 

Li W, McIntyre TM, Silverstein RL. Ferric chloride-induced murine carotid arterial injury: A model of redox pathology. Redox Biol. 2013;1:50–5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Karpov AA, Vaulina DD, Smirnov SS, Moiseeva OM, Galagudza MM. Rodent models of pulmonary embolism and chronic thromboembolic pulmonary hypertension. Heliyon. 2022;8:e09014.

Article  CAS  PubMed  PubMed Central  Google Scholar